Hadas Nicole R.

Avg. Two Year Performance

No purchase track record

29% Avg. Sale Return

14% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	8%	1%	11%	15%	29%
Sale Success Rate	10 of 15	5 of 15	5 of 15	5 of 15	8 of 15

Akebia Therapeutics, Inc.

Drugs » Biotechnology

SVP, Chief Legal Officer:

Holdings: 663.26K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--